Clinical manifestation, lifestyle, and treatment patterns of chronic erosive gastritis: A multicenter real-world study in China

doi:10.3748/wjg.v30.i9.1108

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2155)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-6) series.

Item

Count

PDF

HTML

1579

Figures (1-2)

Tables (1-6)

Sum=1823

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

185

Sum=250

Mar 7, 2024 (publication date) through Jul 17, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. Mar 7, 2024; 30(9): 1108-1120
Published online Mar 7, 2024. doi: 10.3748/wjg.v30.i9.1108

Table 3 Treatment patterns of chronic erosive gastritis, n (%)

Variable	n = 3563	Variable	n = 3563
Treatment patterns
Only lifestyle instructions	368 (10.3)
Drug combinations		Drug by category
MPA + PPI	1126 (31.6)	MPA	2380 (66.8)
MPA	392 (11.0)	PPI	2489 (69.9)
PPI	325 (9.1)	Anti-Hp	404 (11.3)
MPA + PPI + PD	302 (8.5)	H₂RA	23 (0.6)
PPI + anti-Hp	161 (4.5)	PD	608 (17.1)
MPA + PPI + anti-Hp	151 (4.2)	TCM	250 (7.0)
MPA + PD	92 (2.6)	Others	260 (7.3)
MPA + PPI + TCM	65 (1.8)
PPI + PD	51 (1.4)
PPI + TCM	42 (1.2)
Others	488 (13.7)

MPA: Mucosal protective agent; PPI: Proton pump inhibitor; PD: Prokinetic drug; Hp: Helicobacter pylori; TCM: Traditional Chinese medicine; H₂RA: Histamine-2 receptor antagonist.

Citation: Yang YY, Li KM, Xu GF, Wang CD, Xiong H, Wang XZ, Wang CH, Zhang BY, Jiang HX, Sun J, Xu Y, Zhang LJ, Zheng HX, Xing XB, Wang LJ, Zuo XL, Ding SG, Lin R, Chen CX, Wang XW, Li JN. Clinical manifestation, lifestyle, and treatment patterns of chronic erosive gastritis: A multicenter real-world study in China. World J Gastroenterol 2024; 30(9): 1108-1120
URL: https://www.wjgnet.com/1007-9327/full/v30/i9/1108.htm
DOI: https://dx.doi.org/10.3748/wjg.v30.i9.1108